These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2430911)
1. Lymphocyte-induced angiogenesis: correlation with the metastatic incidence of two murine mammary adenocarcinomas. Miguez M; Davel L; de Lustig ES Invasion Metastasis; 1986; 6(5):313-20. PubMed ID: 2430911 [TBL] [Abstract][Full Text] [Related]
2. [Modulation of angiogenesis induced by lymphocytes by extracellular matrix proteins]. Eiján AM; Davel L; de Lustig ES Acta Physiol Pharmacol Ther Latinoam; 1993; 43(3-4):53-7. PubMed ID: 7540077 [TBL] [Abstract][Full Text] [Related]
3. [Immunoregulation of tumor growth in a murine model]. de Bonaparte YP; Colombo L; Davel L; Diament M; Eiján AM; Jasnis MA; Klein S; de Kohan SS; Oisgold-Daga S; Stillitani I Medicina (B Aires); 1989; 49(3):265-70. PubMed ID: 2487420 [TBL] [Abstract][Full Text] [Related]
4. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. Fu Y; Paul RD; Wang Y; Lopez DM J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775 [TBL] [Abstract][Full Text] [Related]
5. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas. Fulton AM; Heppner GH Cancer Res; 1985 Oct; 45(10):4779-84. PubMed ID: 4027966 [TBL] [Abstract][Full Text] [Related]
6. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma. Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768 [TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression. Fiszman G; Cattaneo V; de la Torre E; Español A; Colombo L; Sacerdote de Lustig E; Sales ME Int Immunopharmacol; 2006 Aug; 6(8):1323-30. PubMed ID: 16782546 [TBL] [Abstract][Full Text] [Related]
8. Modified adhesion behavior after in vitro passage of two related murine mammary adenocarcinomas with different metastasizing ability. Bal de Kier Joffé E; Puricelli L; de Lustig ES Invasion Metastasis; 1986; 6(5):302-12. PubMed ID: 3781787 [TBL] [Abstract][Full Text] [Related]
9. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters. Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206 [TBL] [Abstract][Full Text] [Related]
10. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice. Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191 [TBL] [Abstract][Full Text] [Related]
11. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat. Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Sidky YA; Borden EC Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of the incidence of metastasis in tumor-resected mice. Influence of soluble tumor extract and splenectomy. Klein S; de Bonaparte YP; de D'Elia I Invasion Metastasis; 1985; 5(5):309-16. PubMed ID: 4030247 [TBL] [Abstract][Full Text] [Related]
14. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model. Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173 [TBL] [Abstract][Full Text] [Related]
15. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451 [TBL] [Abstract][Full Text] [Related]
16. Invasiveness in vitro of two mammary adenocarcinoma tumors with different metastasizing ability. Puricelli L; Colombo LL; Bal de Kier Joffé E; de Lustig ES Invasion Metastasis; 1984; 4(4):238-46. PubMed ID: 6533095 [TBL] [Abstract][Full Text] [Related]
17. A granulocytosis-inducing tumor inhibits the production of B lymphocytes in murine bone marrow. Fülöp G; Lee MY; Rosse C J Immunol; 1985 Dec; 135(6):4266-72. PubMed ID: 3877765 [TBL] [Abstract][Full Text] [Related]
18. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer]. Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639 [TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis. Rimmaudo LE; de la Torre E; Sacerdote de Lustig E; Sales ME Biochem Biophys Res Commun; 2005 Sep; 334(4):1359-64. PubMed ID: 16040004 [TBL] [Abstract][Full Text] [Related]
20. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein. Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]